Search
Returning search results with filters:
Remove filter for
Audience: Health professionals
Remove filter for
Category: Drugs
Remove filter for
Last updated: 2022
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
- (-) 2022
- December 20222 results available
- November 20221 results available
- October 20221 results available
- August 20224 results available
- June 20221 results available
- April 20221 results available
- March 20223 results available
- February 20226 results available
- January 20227 results available
Recall class
Displaying 1 - 15 of 26 items.
OCALIVA (obeticholic acid) – New Contraindication for the Treatment of Primary Biliary Cholangitis (PBC)
AlertHealth professional risk communication | 2022-12-05
Privigen: Series of adverse reactions
RecallHealth product recall | 2022-12-01
Canadian labelling for all JAK inhibitors to include risks of serious heart-related problems, fatal blood clots and cancer
AlertPublic advisory | 2022-11-01
Janus Kinase Inhibitors and the Risk of Major Adverse Cardiovascular Events, Thrombosis (Including Fatal Events) and Malignancy
AlertHealth professional risk communication | 2022-10-31
IMBRUVICA (ibrutinib) - Risk of Serious and Fatal Cardiac Arrhythmias or Cardiac Failure
AlertHealth professional risk communication | 2022-08-29
PMS-Hydromorphone: Affected lot may contain tablets that could potentially lead to overdose
RecallHealth product recall | 2022-08-22
Recall of one lot of pms-Hydromorphone due to packaging error that could potentially lead to overdose
AlertPublic advisory | 2022-08-20
Sodium Chloride Inj; Glass particles
RecallHealth product recall | 2022-08-02
Red Woody & Go-Rilla - Undeclared prescription drug sildenafil.
RecallHealth product recall | 2022-06-01
Distribution of EVUSHELD (tixagevimab and cilgavimab for injection) with English-Only Vial and Carton Labels
AlertHealth professional risk communication | 2022-04-14
Sodium Acetate Injection, USP - Potential for the Presence of Particulate Matter
AlertHealth professional risk communication | 2022-03-15
0.9% Sodium Chloride Injection, USP and Lactated Ringer’s Injection, USP - Potential Leak During Pressure Infusion
AlertHealth professional risk communication | 2022-03-09
Heparin Sodium and 0.9% Sodium Chloride Injection: leak in intravenous bag
RecallHealth product recall | 2022-03-07
0.9% Sodium Chloride Injection USP: Leaking solution bag
RecallHealth product recall | 2022-02-28
Distribution of NUVAXOVID with English-only Vial and Carton Labels
AlertHealth professional risk communication | 2022-02-23